Jules72 Interesting question though is who decides the new modified boosters should be produced? It won’t be the pharmas because they stand to make more money from vaccines that are used as regularly as possible…
Yeah - it’s a bit of a mess huh? I think the pharma companies will continue to push their existing products if (and it’s a massive if…) they continue to show efficacy against whatever emerging variant is out there. Again, let’s hope this is the last big go around on variant outbreaks…
That said, I read earlier this week that AZ/Oxford University have been working on an updated version of their vaccine specifically targeting Omicron.
Let’s hope this time next year we’re getting our first annual COVID vaccination?